Athens World Coffee Championships greekcitytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from greekcitytimes.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
NEW YORK and SAN DIEGO, Feb. 18, 2021 /PRNewswire/ Ensysce Biosciences Inc. ( Ensysce ), a clinical stage pharmaceutical company developing medicines for severe pain relief to reduce fear of addiction, opioid misuse, abuse and overdose, and Leisure Acquisition Corp. (NASDAQ: LACQ) ( LACQ ) today announced the appointment of David Humphrey to Ensysce s management team as its Chief Financial Officer.
Mr. Humphrey brings over 20 years of experience with development-stage companies as they progress toward product commercialization. Prior to joining Ensysce, Mr. Humphrey was Chief Financial Officer of Senomyx, Inc., a publicly-held biotechnology company which he led through an acquisition by Firmenich SA, a private Swiss multinational flavor and fragrance company. As part of his responsibilities, he will oversee financial strategy and business expansion at Ensysce, in addition to assisting with Ensysce s proposed business combination with LA